0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease Drug Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-1529
Home | Market Reports | Health | Aging & Geriatrics
Global Alzheimer s Disease Drug Market Insights and Forecast to 2028

Global Alzheimer's Disease Drug Market Insights and Forecast to 2028

Code: QYRE-Auto-1529
Report
January 2022
91 Pages
QYResearch
Region: North America, Asia-PacificEurope, Central & South AmericaRest of Central & South America, Middle East & Africa, Global, Europe, Asia Pacific, Africa, Middle East, China,
Description
Table of Content
Tables & Figures
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Market Analysis and Insights: Global Alzheimer's Disease Drug Market

Due to the COVID-19 pandemic, the global Alzheimer's Disease Drug market size is estimated to be worth US$ 3676.9 million in 2022 and is forecast to a readjusted size of US$ 4020.5 million by 2028 with a CAGR of 1.5% during the review period.

Fully considering the economic change by this health crisis, Donepezil accounting for % of the Alzheimer's Disease Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Early to Moderate Stages segment is altered to an % CAGR throughout this forecast period.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
Global Alzheimer's Disease Drug Scope and Segment
Alzheimer's Disease Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Donepezil
Memantine
Rivastigmine
Others

Segment by Application

Early to Moderate Stages
Moderate to Severe Stages

BY COMPANY

Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Alzheimer's Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alzheimer's Disease Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Alzheimer's Disease Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Alzheimer's Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Alzheimer's Disease Drug Sales by Region
2.4.1 Global Alzheimer's Disease Drug Sales by Region (2017-2022)
2.4.2 Global Sales Alzheimer's Disease Drug by Region (2023-2028)
2.5 Global Alzheimer's Disease Drug Revenue by Region
2.5.1 Global Alzheimer's Disease Drug Revenue by Region (2017-2022)
2.5.2 Global Alzheimer's Disease Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Alzheimer's Disease Drug Sales by Manufacturers
3.1.1 Global Top Alzheimer's Disease Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alzheimer's Disease Drug in 2021
3.2 Global Alzheimer's Disease Drug Revenue by Manufacturers
3.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Alzheimer's Disease Drug Revenue in 2021
3.3 Global Alzheimer's Disease Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Alzheimer's Disease Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alzheimer's Disease Drug Sales by Type
4.1.1 Global Alzheimer's Disease Drug Historical Sales by Type (2017-2022)
4.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
4.2 Global Alzheimer's Disease Drug Revenue by Type
4.2.1 Global Alzheimer's Disease Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
4.3 Global Alzheimer's Disease Drug Price by Type
4.3.1 Global Alzheimer's Disease Drug Price by Type (2017-2022)
4.3.2 Global Alzheimer's Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Alzheimer's Disease Drug Sales by Application
5.1.1 Global Alzheimer's Disease Drug Historical Sales by Application (2017-2022)
5.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
5.2 Global Alzheimer's Disease Drug Revenue by Application
5.2.1 Global Alzheimer's Disease Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
5.3 Global Alzheimer's Disease Drug Price by Application
5.3.1 Global Alzheimer's Disease Drug Price by Application (2017-2022)
5.3.2 Global Alzheimer's Disease Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Alzheimer's Disease Drug Market Size by Type
6.1.1 North America Alzheimer's Disease Drug Sales by Type (2017-2028)
6.1.2 North America Alzheimer's Disease Drug Revenue by Type (2017-2028)
6.2 North America Alzheimer's Disease Drug Market Size by Application
6.2.1 North America Alzheimer's Disease Drug Sales by Application (2017-2028)
6.2.2 North America Alzheimer's Disease Drug Revenue by Application (2017-2028)
6.3 North America Alzheimer's Disease Drug Market Size by Country
6.3.1 North America Alzheimer's Disease Drug Sales by Country (2017-2028)
6.3.2 North America Alzheimer's Disease Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Alzheimer's Disease Drug Market Size by Type
7.1.1 Europe Alzheimer's Disease Drug Sales by Type (2017-2028)
7.1.2 Europe Alzheimer's Disease Drug Revenue by Type (2017-2028)
7.2 Europe Alzheimer's Disease Drug Market Size by Application
7.2.1 Europe Alzheimer's Disease Drug Sales by Application (2017-2028)
7.2.2 Europe Alzheimer's Disease Drug Revenue by Application (2017-2028)
7.3 Europe Alzheimer's Disease Drug Market Size by Country
7.3.1 Europe Alzheimer's Disease Drug Sales by Country (2017-2028)
7.3.2 Europe Alzheimer's Disease Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Alzheimer's Disease Drug Market Size by Type
8.1.1 Asia Pacific Alzheimer's Disease Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Alzheimer's Disease Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Alzheimer's Disease Drug Market Size by Application
8.2.1 Asia Pacific Alzheimer's Disease Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Alzheimer's Disease Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Alzheimer's Disease Drug Market Size by Region
8.3.1 Asia Pacific Alzheimer's Disease Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Alzheimer's Disease Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Alzheimer's Disease Drug Market Size by Type
9.1.1 Latin America Alzheimer's Disease Drug Sales by Type (2017-2028)
9.1.2 Latin America Alzheimer's Disease Drug Revenue by Type (2017-2028)
9.2 Latin America Alzheimer's Disease Drug Market Size by Application
9.2.1 Latin America Alzheimer's Disease Drug Sales by Application (2017-2028)
9.2.2 Latin America Alzheimer's Disease Drug Revenue by Application (2017-2028)
9.3 Latin America Alzheimer's Disease Drug Market Size by Country
9.3.1 Latin America Alzheimer's Disease Drug Sales by Country (2017-2028)
9.3.2 Latin America Alzheimer's Disease Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Type
10.1.1 Middle East and Africa Alzheimer's Disease Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Alzheimer's Disease Drug Market Size by Application
10.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Alzheimer's Disease Drug Market Size by Country
10.3.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Eisai
11.2.1 Eisai Corporation Information
11.2.2 Eisai Overview
11.2.3 Eisai Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eisai Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Overview
11.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daiichi Sankyo Recent Developments
11.5 Merz Pharma
11.5.1 Merz Pharma Corporation Information
11.5.2 Merz Pharma Overview
11.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merz Pharma Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Corporation Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lundbeck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alzheimer's Disease Drug Industry Chain Analysis
12.2 Alzheimer's Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alzheimer's Disease Drug Production Mode & Process
12.4 Alzheimer's Disease Drug Sales and Marketing
12.4.1 Alzheimer's Disease Drug Sales Channels
12.4.2 Alzheimer's Disease Drug Distributors
12.5 Alzheimer's Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Alzheimer's Disease Drug Industry Trends
13.2 Alzheimer's Disease Drug Market Drivers
13.3 Alzheimer's Disease Drug Market Challenges
13.4 Alzheimer's Disease Drug Market Restraints
14 Key Findings in The Global Alzheimer's Disease Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Donepezil
    Table 3. Major Manufacturers of Memantine
    Table 4. Major Manufacturers of Rivastigmine
    Table 5. Major Manufacturers of Others
    Table 6. Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Alzheimer's Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Alzheimer's Disease Drug Sales by Region (2017-2022) & (M Units)
    Table 9. Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Alzheimer's Disease Drug Sales by Region (2023-2028) & (M Units)
    Table 11. Global Alzheimer's Disease Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Alzheimer's Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Alzheimer's Disease Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Alzheimer's Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Alzheimer's Disease Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Alzheimer's Disease Drug Sales by Manufacturers (2017-2022) & (M Units)
    Table 17. Global Alzheimer's Disease Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Alzheimer's Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Alzheimer's Disease Drug Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 21. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2021)
    Table 23. Alzheimer's Disease Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Alzheimer's Disease Drug Product Offered
    Table 25. Date of Manufacturers Enter into Alzheimer's Disease Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 28. Global Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 29. Global Alzheimer's Disease Drug Sales Share by Type (2017-2022)
    Table 30. Global Alzheimer's Disease Drug Sales Share by Type (2023-2028)
    Table 31. Global Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Alzheimer's Disease Drug Revenue Share by Type (2017-2022)
    Table 34. Global Alzheimer's Disease Drug Revenue Share by Type (2023-2028)
    Table 35. Alzheimer's Disease Drug Price by Type (2017-2022) & (US$/Unit)
    Table 36. Global Alzheimer's Disease Drug Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 37. Global Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 38. Global Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 39. Global Alzheimer's Disease Drug Sales Share by Application (2017-2022)
    Table 40. Global Alzheimer's Disease Drug Sales Share by Application (2023-2028)
    Table 41. Global Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Alzheimer's Disease Drug Revenue Share by Application (2017-2022)
    Table 44. Global Alzheimer's Disease Drug Revenue Share by Application (2023-2028)
    Table 45. Alzheimer's Disease Drug Price by Application (2017-2022) & (US$/Unit)
    Table 46. Global Alzheimer's Disease Drug Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 47. North America Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 48. North America Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 49. North America Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 52. North America Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 53. North America Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
    Table 56. North America Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)
    Table 57. North America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 60. Europe Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 61. Europe Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 64. Europe Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 65. Europe Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
    Table 68. Europe Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)
    Table 69. Europe Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 72. Asia Pacific Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 73. Asia Pacific Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 76. Asia Pacific Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 77. Asia Pacific Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Alzheimer's Disease Drug Sales by Region (2017-2022) & (M Units)
    Table 80. Asia Pacific Alzheimer's Disease Drug Sales by Region (2023-2028) & (M Units)
    Table 81. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 84. Latin America Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 85. Latin America Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 88. Latin America Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 89. Latin America Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
    Table 92. Latin America Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)
    Table 93. Latin America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
    Table 96. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)
    Table 97. Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
    Table 100. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)
    Table 101. Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
    Table 104. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)
    Table 105. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Allergan Corporation Information
    Table 108. Allergan Description and Major Businesses
    Table 109. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Allergan Recent Developments
    Table 112. Eisai Corporation Information
    Table 113. Eisai Description and Major Businesses
    Table 114. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Eisai Recent Developments
    Table 117. Novartis Corporation Information
    Table 118. Novartis Description and Major Businesses
    Table 119. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Novartis Recent Developments
    Table 122. Daiichi Sankyo Corporation Information
    Table 123. Daiichi Sankyo Description and Major Businesses
    Table 124. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Daiichi Sankyo Recent Developments
    Table 127. Merz Pharma Corporation Information
    Table 128. Merz Pharma Description and Major Businesses
    Table 129. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Merz Pharma Recent Developments
    Table 132. Pfizer Corporation Information
    Table 133. Pfizer Description and Major Businesses
    Table 134. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Pfizer Recent Developments
    Table 137. Johnson & Johnson Corporation Information
    Table 138. Johnson & Johnson Description and Major Businesses
    Table 139. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Johnson & Johnson Recent Developments
    Table 142. Lundbeck Corporation Information
    Table 143. Lundbeck Description and Major Businesses
    Table 144. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 145. Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Lundbeck Recent Developments
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Alzheimer's Disease Drug Distributors List
    Table 150. Alzheimer's Disease Drug Customers List
    Table 151. Alzheimer's Disease Drug Market Trends
    Table 152. Alzheimer's Disease Drug Market Drivers
    Table 153. Alzheimer's Disease Drug Market Challenges
    Table 154. Alzheimer's Disease Drug Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Disease Drug Product Picture
    Figure 3. Global Alzheimer's Disease Drug Market Share by Type in 2021 & 2028
    Figure 3. Donepezil Product Picture
    Figure 4. Memantine Product Picture
    Figure 5. Rivastigmine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Alzheimer's Disease Drug Market Share by Application in 2021 & 2028
    Figure 8. Early to Moderate Stages
    Figure 9. Moderate to Severe Stages
    Figure 10. Alzheimer's Disease Drug Report Years Considered
    Figure 11. Global Alzheimer's Disease Drug Sales 2017-2028 (M Units)
    Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Alzheimer's Disease Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Alzheimer's Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Alzheimer's Disease Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)
    Figure 18. North America Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)
    Figure 20. Europe Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)
    Figure 22. Asia-Pacific Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)
    Figure 24. Latin America Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)
    Figure 26. Middle East & Africa Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Alzheimer's Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Alzheimer's Disease Drug in the World: Market Share by Alzheimer's Disease Drug Revenue in 2021
    Figure 29. Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Alzheimer's Disease Drug Sales Share by Country (2017-2028)
    Figure 39. North America Alzheimer's Disease Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Alzheimer's Disease Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Alzheimer's Disease Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Alzheimer's Disease Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Alzheimer's Disease Drug Revenue Share by Region (2017-2028)
    Figure 59. China Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Alzheimer's Disease Drug Sales Share by Country (2017-2028)
    Figure 73. Latin America Alzheimer's Disease Drug Revenue Share by Country (2017-2028)
    Figure 74. Mexico Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Colombia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Alzheimer's Disease Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Alzheimer's Disease Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Alzheimer's Disease Drug Value Chain
    Figure 88. Alzheimer's Disease Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Alzheimer s Disease Market Insights and Forecast to 2028
Global Alzheimer's Disease Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-35R2945
Tue Sep 27 00:00:00 UTC 2022

Add to Cart

Global Alzheimer s Disease Diagnostic Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global Alzheimer's Disease Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-35E12001
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-27H11910
Tue Sep 13 00:00:00 UTC 2022

Add to Cart

Global Familial Amyloid Polyneuropathy Therapeutic Market Research Report 2022
Global Familial Amyloid Polyneuropathy Therapeutic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-3V12140
Wed Aug 31 00:00:00 UTC 2022

Add to Cart